Navigation Links
Ellman International Announces New US Sales Executive
Date:4/1/2011

OCEANSIDE, N.Y., April 1, 2011 /PRNewswire/ -- Ellman International, Inc., a New York based manufacturer of radiofrequency (RF) devices for surgical and aesthetic procedures, today announced the appointment of Dennis S. Herman to the position of Senior Vice President, US Sales.

Herman brings over 20 years of sales leadership and aesthetic market experience with leading companies to Ellman.  "Dennis' proven success in leading sales teams to significant revenue growth coupled with his expertise in energy based surgical and aesthetic markets will be of great value as we further strengthen our position as a leader in both of these important sectors," said Chief Executive Officer Rick Epstein.

Most recently, Herman served as Senior VP of North American Sales for Candela Laser Corporation where his sales leadership resulted in growth of the business to the top position in the industry.  He has also held sales management positions of increasing responsibility at Palomar Medical Technology, Inc. including its subsidiary Spectrum Medical Technologies, Inc.

"I am pleased to be joining Ellman at such an exciting time and look forward to leading the US sales team to further success in the both the surgical and aesthetic markets," said Herman.

"Dennis is recognized for inspiring trust, loyalty and respect among his sales team, his customers and thought leaders in Dermatology.  His knowledge and expertise will be an excellent complement to our management team," added Epstein.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) maker of the Pelleve™ Wrinkle Reduction System, a revolutionary skin tightening system for non-ablative skin rejuvenation is a privately held developer, manufacturer and marketer of high frequency electrosurgical devices.  Ellman is a trusted leader in products for surgical procedures requiring cutting, coagulating, and tissue ablation in physician's offices and clinics. The company's advanced technologies offer unique versatility and precision to the surgical and aesthetic markets. In 2008, Baird Capital Partners and an investment group which includes Ellman's senior executives acquired Ellman.  

© 2011 Ellman International, Inc. All Rights Reserved.

ellman® International, Inc.

3333 Royal Avenue, Oceanside, N.Y. 11572-3625 U.S.A.

(800) 835-5355 • Fax: (516) 569-0054 • www.ellman.com

For more information, visit www.ellman.com and www.pelleve.com


'/>"/>
SOURCE Ellman International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ellman International Announces Executive Team Hire
2. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
5. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
6. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
7. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
8. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
9. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):